A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)
Clinical trial NCT01655992 · TERMINATED
Trial details
- NCT number
- NCT01655992
- Sponsor
- Fudan University
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2017-10-01
- Enrollment
- 386
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.